Article
A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy
10 Aug 2021
Abstract excerpt
BACKGROUND: Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explored the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy, as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
